相关实验视频

Updated: Jun 3, 2025

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

在上皮卵巢癌中加入免疫检查点抑制剂

Giorgio Bogani¹, Kathleen N Moore², Isabelle Ray-Coquard³

¹Deaprtment of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Gynecologic oncology

|January 7, 2025

概括

免疫检查点抑制剂 (CPI) 作为表皮卵巢癌 (EOC) 的单一疗法具有有限的疗效. 组合疗法和新型CPI组合正在研究中,以改善EOC患者的治疗结果.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
妇科癌症妇科癌症

背景情况:

除了生物标志物选择疗法外,上皮卵巢癌 (EOC) 治疗的进展有限.
尽管取得了进展,但仍有急需改进的EOC治疗方法,以延长生存和生活质量.
免疫检查点抑制剂 (CPI) 已在其他固体瘤中取得成功,但它们在EOC中的有效性仍在评估中.

研究的目的:

系统地审查评估CPI在卵巢癌中的作用的III期临床试验.
评估CPI单疗法和组合疗法在不同EOC环境中的疗效.
确定在EOC治疗中免疫治疗的潜在未来方向.

主要方法:

进行了对III期随机试验的系统审查,这些试验涉及卵巢癌中CPI.
分析了7项试验中5671名患者的数据,包括新诊断和复发性EOC.
试验评估了单剂CPI,维持疗法以及对敏感/耐药的EOC种群.

主要成果:

单剂PD-L1抑制剂在新诊断的EOC中没有显著的疗效.
三次维护疗法 (贝瓦西祖马布,奥拉帕里布,杜尔瓦卢马布) 在非BRCA突变的EOC中比单独的贝瓦西祖马布改善了无进展生存期.
在敏感或耐药的EOC中,CPI没有显著的有效性.

结论:

将CPI添加到标准治疗的好处,如带有或没有bevacizumab的PARP抑制剂,仍然不确定,目前正在进行试验.
结合细胞毒性T淋巴细胞相关蛋白4 (CTLA-4) 和编程细胞死亡蛋白1 (PD-1) 抑制剂,可能会提高EOC的免疫治疗疗效.
进一步的研究正在调查CPI组合与EOC的新疗法.

关键词:

豁免权是一种豁免权.免疫治疗是一种免疫疗法.卵巢癌是发生在卵巢中的癌症.这是一种PARP抑制剂.

更多相关视频

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...